Thiotepa Containing Regimen As Conditioning Chemotherapy for Lymphoma Involving Central Nervous System Compared with BuCyE (Busulfan, Cyclophosphamide and Etoposide)

被引：0
|
作者：
Kim, Yi Rang [1 ]
Yoon, Dok Hyun [1 ]
Kim, Shin [1 ]
Lee, Kyoungmin [1 ]
Kang, Eun Hee [1 ]
Park, Jung Sun [1 ]
Yoo, Changhoon [1 ]
Kim, Jeong-eun [1 ]
Jo, Jae-Cheol [2 ]
Huh, Jooryung [3 ]
Kim, Jeong Hoon [4 ]
Lee, Sang-wook [5 ]
Suh, Cheolwon [1 ]
机构：
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea
[2] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Hematol & Oncol, Ulsan 680749, South Korea
[3] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea
[4] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Neurosurg, Seoul, South Korea
[5] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiat Oncol, Seoul, South Korea
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] IBRUTINIB COMPARED TO STANDARD CHEMOTHERAPY FOR CENTRAL NERVOUS SYSTEM RECURRENCE OF MANTLE CELL LYMPHOMA
    Rusconi, C.
    Tucker, D.
    Bernard, S.
    Muzi, C.
    Crucitti, L.
    Stefani, P. M.
    Cox, M. C.
    Gini, G.
    Re, A.
    Sciarra, R.
    Liberati, A. M.
    Morello, L.
    Arcari, A.
    Mannina, D.
    Vitagliano, O.
    Sartori, R.
    Chiappella, A.
    Balzarotti, M.
    Vitolo, U.
    Thieblemont, C.
    Rule, S.
    Visco, C.
    HAEMATOLOGICA, 2019, 104 : 47 - 47
  • [42] High dose thiotepa, busulfan, cyclophosphamide (TBC) and autologous hematopoietic stem cell transplantation (ASCT) without whole brain radiotherapy (WBRT) for primary central nervous system lymphoma (PCNSL).
    Stewart, DA
    Forsyth, P
    Chaudhry, A
    Jeje, O
    Morris, D
    Savoie, L
    Brown, C
    Russell, JR
    BLOOD, 2004, 104 (11) : 261A - 261A
  • [43] Prolonged third complete remission after busulfan, thiotepa, and autologous stem cell transplant in a primary central nervous system lymphoma patient
    Camus, Vincent
    Dubois, Sydney
    Lepretre, Stephane
    Jardin, Fabrice
    Tilly, Herve
    CLINICAL CASE REPORTS, 2018, 6 (08): : 1418 - 1421
  • [44] INTENSIVE CHEMOTHERAPY WITH THIOTEPA, BUSULFAN, AND CYCLOPHOSPHAMIDE (TT-BU-CY) WITH HEMATOPOIETIC STEM CELL RESCUE (IC+HCR) IN RELAPSED OR REFRACTORY PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL) OR INTRAOCULAR LYMPHOMA (IOL): A RETROSPECTIVE STUDY OF 74 CASES
    Soussain, C.
    Choquet, S.
    Fourme, E.
    Bouabdallah, K.
    Ghesquieres, H.
    Damaj, G.
    Dupriez, B.
    Gonzalez, A.
    Taillandier, L.
    Hoang-Xuan, K.
    Leblond, V.
    ANNALS OF ONCOLOGY, 2011, 22 : 93 - 93
  • [45] Patients with Central Nervous System Lymphoma (CNSL) Undergoing Thiotepa, Busulfan, Cyclophosphamide-Conditioned Autologous Stem Cell Transplantation (TBC-ASCT) are at a Higher Risk for DNA Virus Infections Than Patients Receiving Traditional Conditioning
    Scordo, Michael
    Morjaria, Sejal M.
    Bhatia, Ankush
    Littman, Eric
    Maloy, Molly
    DeAngelis, Lisa
    Giralt, Sergio A.
    Taur, Ying
    Sauter, Craig S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S37 - S38
  • [46] Ibrutinib improves survival compared with chemotherapy in mantle cell lymphoma with central nervous system relapse
    Rusconi, Chiara
    Cheah, Chan Y.
    Eyre, Toby A.
    Tucker, David
    Klener, Pavel
    Gine, Eva
    Crucitti, Lara
    Muzi, Cristina
    Iadecola, Sara
    Infante, Gabriele
    Bernard, Sophie
    Auer, Rebecca L.
    Pagani, Chiara
    Duglosz-Danecka, Monika
    Mocikova, Heidi
    van Meerten, Tom
    Cencini, Emanuele
    Marin-Niebla, Ana
    Williams, Michael E.
    Angelillo, Piera
    Nicoli, Paolo
    Arcari, Annalisa
    Morello, Lucia
    Mannina, Donato
    Vitagliano, Orsola
    Sartori, Roberto
    Chiappella, Annalisa
    Sciarra, Roberta
    Stefani, Piero M.
    Dreyling, Martin
    Seymour, John F.
    Visco, Carlo
    BLOOD, 2022, 140 (17) : 1907 - 1916
  • [47] Busulfan, Melphalan, and Thiotepa Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) of Pediatric Patients with Acute Leukemia and Central Nervous System (CNS) Disease
    Forlenza, Christopher J.
    Kobos, Rachel
    Kernan, Nancy A.
    Scaradavou, Andromachi
    Prockop, Susan E.
    Curran, Kevin
    Shukla, Neerav
    Steinherz, Peter G.
    O'Reilly, Richard
    Boulad, Farid
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S169 - S169
  • [48] Yttrium-90-Ibritumomab Tiuxetan and BuCyE High-Dose Chemotherapy Compared with BuCyE Alone As Conditioning Regimen in Patients with B-Cell Non-Hodgkin Lymphoma: IPI Matched Case Control Study At a Single Center
    Jo, Jae-Cheol
    Yoon, Dok Hyun
    Kim, Shin
    Jang, Seongsoo
    Park, Chan-Jeoung
    Chi, Hyun Sook
    Park, Chan-Sik
    Huh, Jooryung
    Lee, Sang-wook
    Suh, Cheolwon
    BLOOD, 2011, 118 (21) : 1581 - 1582
  • [49] Outcomes Associated With Thiotepa-Based Conditioning in Patients With Primary Central Nervous System Lymphoma After Autologous Hematopoietic Cell Transplant
    Scordo, Michael
    Wang, Trent P.
    Ahn, Kwang W.
    Chen, Yue
    Ahmed, Sairah
    Awan, Farrukh T.
    Beitinjaneh, Amer
    Chen, Andy
    Chow, Victor A.
    Dholaria, Bhagirathbhai
    Epperla, Narendranath
    Farooq, Umar
    Ghosh, Nilanjan
    Grover, Natalie
    Hamad, Nada
    Hildebrandt, Gerhard C.
    Holmberg, Leona
    Hong, Sanghee
    Inwards, David J.
    Jimenez-Jimenez, Antonio
    Karmali, Reem
    Kenkre, Vaishalee P.
    Khimani, Farhad
    Klyuchnikov, Evgeny
    Krem, Maxwell M.
    Munshi, Pashna N.
    Nieto, Yago
    Prestidge, Tim
    Ramakrishnan Geethakumari, Praveen
    Rezvani, Andrew R.
    Riedell, Peter A.
    Seo, Sachiko
    Shah, Nirav N.
    Solh, Melhem
    Yared, Jean A.
    Kharfan-Dabaja, Mohamed A.
    Herrera, Alex
    Hamadani, Mehdi
    Sauter, Craig S.
    JAMA ONCOLOGY, 2021, 7 (07) : 993 - 1003
  • [50] OUTCOMES OF CENTRAL NERVOUS SYSTEM LYMPHOMA TREATED WITH NON-THIOTEPA BASED CONSOLIDATION CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANT
    Vegel, A.
    Safah, H.
    Socola, F.
    Ziglar, N.
    Rink, J.
    Entwisle, S.
    Saba, N. S.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2022, 70 (02) : 566 - 566
12345